Stay updated with breaking news from Casirivimab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(2) Press Release: EMA issues advice on casirivimab and imdevimab antibody cocktail for the treatment of mild-to-moderate COVID-19 CHMP has completed a review of available data for investigational antibody cocktail casirivimab and imdevimab (REGN-COV2) to be considered for the treatment of confirmed COVID-19 CHMP scientific opinion supports national decision making within EU states on the use of the antibodies before a formal authorisation is granted during a public health emergency Roche and Regeneron are collaborating on developing and manufacturing casirivimab and imdevimab; Roche will be responsible for distribution in Europe and other countries outside the US Basel, 26 February 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) confirmed ....
Roche: CHMP Opinion Supports Use Of Casirivimab-imdevimab Antibody Cocktail For COVID Treatment SOUTH SAN FRANCISCO (dpa-AFX) - Roche (RHHBY) confirmed Friday that the European Medicines Agency s or EMA Committee for Medicinal Products for Human Use or CHMP has issued a scientific opinion supporting the use of the investigational antibody cocktail, casirivimab and imdevimab, as a treatment option for patients with confirmed COVID-19 who do not require oxygen supplementation and who are at high risk of progressing to severe COVID-19. The CHMP scientific opinion supports national decision making within EU states on the use of the antibodies before a formal authorisation is granted during a public health emergency. ....